Source: PR Newswire

Press Release: Salix Pharmaceuticals : Salix Announces 2022 Gastrointestinal Health Scholars Program Winners

For Third Consecutive Year, 10 Students with Gastrointestinal Disease Will Each Receive a $10,000 Scholarship LAVAL, QC, July 13, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its gastroenterology business, Salix Pharmaceuticals, ("Salix"), one of...

Read full article »
Est. Annual Revenue
$1.0-5.0B
Agree?
Est. Employees
500-1.0K
Agree?
Robert Spurr's photo - President of Salix Pharmaceuticals

President

Robert Spurr

CEO Approval Rating

82/100

Read more